PRGO
Perrigo Company plc NYSE Listed Dec 17, 1991$11.71
Mkt Cap $1.6B
52w Low $9.23
12.9% of range
52w High $28.44
50d MA $11.01
200d MA $16.63
P/E (TTM)
-1.2x
EV/EBITDA
-6.7x
P/B
0.6x
Debt/Equity
1.4x
ROE
-48.6%
P/FCF
13.3x
RSI (14)
—
ATR (14)
—
Beta
0.49
50d MA
$11.01
200d MA
$16.63
Avg Volume
3.3M
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
The Sharp Building · Dublin, L2 2 · IE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BMO | 0.80 | 0.77 | -3.8% | 14.19 | -0.9% | -6.8% | -6.7% | -7.7% | +2.6% | -4.2% | — |
| Nov 5, 2025 | BMO | 0.75 | 0.80 | +6.7% | 15.10 | +0.8% | -1.1% | -3.3% | -1.3% | +0.4% | -1.0% | — |
| Aug 6, 2025 | BMO | 0.59 | 0.57 | -3.4% | 23.61 | +0.6% | -3.3% | -1.2% | -2.4% | +4.8% | +2.6% | — |
| May 7, 2025 | BMO | 0.56 | 0.60 | +7.1% | 26.41 | -0.6% | +1.5% | +0.8% | -0.1% | -2.9% | -0.8% | — |
| Feb 27, 2025 | BMO | 0.92 | 0.93 | +1.1% | 24.13 | +14.6% | +20.2% | +0.0% | +1.0% | +0.6% | -2.7% | — |
| Nov 6, 2024 | BMO | 0.82 | 0.81 | -1.2% | 27.31 | +0.5% | -1.4% | -2.1% | +1.4% | -1.3% | +1.7% | — |
| Aug 2, 2024 | BMO | 0.48 | 0.53 | +10.4% | 27.58 | -3.9% | +4.1% | -1.1% | -2.2% | +0.5% | -3.5% | — |
| May 7, 2024 | BMO | 0.24 | 0.29 | +20.8% | 30.15 | +0.5% | +3.2% | -0.3% | -1.0% | +0.3% | -1.7% | — |
| Feb 27, 2024 | BMO | 0.83 | 0.86 | +3.6% | 27.30 | +0.0% | -3.3% | -0.6% | +0.3% | -0.4% | +3.9% | — |
| Nov 7, 2023 | BMO | 0.65 | 0.64 | -1.5% | 29.62 | +0.0% | -2.0% | -3.2% | +1.1% | -0.8% | +2.6% | — |
| Aug 8, 2023 | BMO | 0.54 | 0.63 | +16.7% | 39.94 | -1.1% | -2.5% | -1.1% | +2.6% | -1.3% | -0.2% | — |
| May 9, 2023 | BMO | 0.42 | 0.45 | +7.1% | 34.88 | +0.3% | +4.5% | -2.6% | -0.8% | -2.8% | -4.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $14.19 | $14.06 | -0.9% | -6.8% | -6.7% | -7.7% | +2.6% | -4.2% |
| Dec 15 | JP Morgan | Maintains | Neutral → Neutral | — | $13.14 | $13.15 | +0.1% | -2.3% | +1.4% | +2.6% | -0.4% | -0.6% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $15.10 | $15.22 | +0.8% | -1.1% | -3.3% | -1.3% | +0.4% | -1.0% |
| Nov 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.10 | $15.22 | +0.8% | -1.1% | -3.3% | -1.3% | +0.4% | -1.0% |
| Oct 27 | Jefferies | Maintains | Hold → Hold | — | $21.46 | $21.46 | +0.0% | +2.2% | -1.5% | -1.5% | -3.0% | +0.5% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $23.61 | $23.75 | +0.6% | -3.3% | -1.2% | -2.4% | +4.8% | +2.6% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $23.61 | $23.75 | +0.6% | -3.3% | -1.2% | -2.4% | +4.8% | +2.6% |
| Jan 6 | Piper Sandler | Downgrade | Overweight → Neutral | — | $25.95 | $25.70 | -1.0% | -2.4% | -1.5% | +0.4% | -2.7% | -0.2% |
| Sep 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $25.65 | $25.68 | +0.1% | +2.3% | -2.9% | -1.5% | -1.3% | +0.7% |
| Sep 23 | Jefferies | Downgrade | Buy → Hold | — | $27.13 | $27.17 | +0.1% | -0.3% | -1.9% | -3.7% | +0.3% | +0.1% |
| Jul 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $27.16 | $27.20 | +0.1% | +2.5% | -1.3% | -2.1% | +0.7% | +2.3% |
| Jun 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $27.84 | $27.48 | -1.3% | -1.6% | -2.0% | -2.3% | -2.6% | +0.2% |
| Apr 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.28 | $31.24 | -0.1% | -3.1% | -0.6% | -0.6% | +0.3% | -0.3% |
| Apr 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $31.40 | $31.70 | +1.0% | +1.1% | +1.5% | -2.1% | -0.8% | -3.1% |
| Feb 28 | JP Morgan | Maintains | Overweight → Overweight | — | $27.30 | $27.31 | +0.0% | -3.3% | -0.6% | +0.3% | -0.4% | +3.9% |
| Aug 9 | JP Morgan | Maintains | Overweight → Overweight | — | $39.94 | $39.51 | -1.1% | -2.5% | -1.1% | +2.6% | -1.3% | -0.2% |
| Mar 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $36.96 | $37.24 | +0.8% | +2.0% | -1.7% | -1.9% | -1.4% | -1.6% |
| Mar 6 | Raymond James | Maintains | Outperform → Outperform | — | $38.75 | $38.51 | -0.6% | -4.6% | +2.0% | -1.7% | -1.9% | -1.4% |
| Nov 9 | Raymond James | Maintains | Outperform → Outperform | — | $33.26 | $32.93 | -1.0% | -3.5% | +2.3% | +1.9% | -2.4% | +0.4% |
| Sep 14 | Argus | Upgrade | Hold → Buy | — | $39.33 | $39.92 | +1.5% | +1.8% | -0.8% | +1.0% | +0.6% | -1.1% |
| Sep 6 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $36.74 | $37.87 | +3.1% | +3.3% | +1.1% | +0.6% | +1.4% | +3.9% |
| May 4 | Raymond James | Maintains | Outperform → Outperform | — | $33.24 | $33.07 | -0.5% | +0.0% | -2.8% | +0.5% | -0.9% | +0.4% |
| Nov 11 | Raymond James | Maintains | Outperform → Outperform | — | $42.21 | $41.73 | -1.1% | +2.6% | +0.0% | -1.2% | +0.5% | -0.6% |
| Oct 14 | Raymond James | Upgrade | Market Perform → Outperform | — | $44.86 | $45.64 | +1.7% | +1.4% | -1.6% | +0.1% | +2.0% | +0.2% |
| Sep 30 | Jefferies | Upgrade | Hold → Buy | — | $43.50 | $50.73 | +16.6% | +8.8% | +2.6% | -0.9% | +0.6% | +0.2% |
| Mar 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $40.57 | $40.76 | +0.5% | +1.2% | +1.9% | -2.1% | +1.6% | -0.6% |
| Jan 6 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $44.27 | $43.48 | -1.8% | +1.3% | +2.6% | -3.0% | -0.1% | +2.4% |
| Oct 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $44.03 | $43.23 | -1.8% | -3.3% | -0.1% | +3.2% | +4.0% | -0.5% |
| Sep 17 | SVB Leerink | Maintains | Outperform → Outperform | — | $49.84 | $46.92 | -5.9% | -2.9% | -2.7% | -2.4% | +1.4% | -2.5% |
| Jun 8 | SVB Leerink | Maintains | Outperform → Outperform | — | $55.61 | $55.62 | +0.0% | +3.8% | -3.1% | -4.5% | -4.2% | +0.5% |
| Apr 17 | Argus | Downgrade | Buy → Hold | — | $50.84 | $51.49 | +1.3% | +2.0% | -1.9% | -2.3% | -0.1% | +2.8% |
| Apr 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $45.11 | $44.00 | -2.5% | -5.1% | +3.6% | +7.2% | -1.0% | +3.8% |
| Mar 24 | JP Morgan | Upgrade | Neutral → Overweight | — | $42.27 | $45.01 | +6.5% | +7.0% | -1.0% | +4.0% | -0.9% | +5.9% |
| Mar 20 | SVB Leerink | Upgrade | Market Perform → Outperform | — | $43.75 | $44.14 | +0.9% | -3.7% | +0.3% | +7.0% | -1.0% | +4.0% |
| Mar 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.48 | $48.05 | -2.9% | -7.0% | -11.7% | +13.8% | -1.6% | +9.0% |
| Jan 21 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $59.02 | $58.77 | -0.4% | +1.4% | -0.6% | +0.0% | -1.2% | -0.2% |
| Oct 11 | Argus | Upgrade | Hold → Buy | — | $52.00 | $53.00 | +1.9% | +2.8% | -0.7% | +1.4% | +0.2% | +0.9% |
| Sep 30 | Wells Fargo | Maintains | Market Perform → Market Perform | — | $54.98 | $55.19 | +0.4% | +1.7% | -1.2% | -1.9% | -1.8% | +0.8% |
| Sep 25 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $54.25 | $54.26 | +0.0% | +1.8% | -2.3% | +1.9% | +1.7% | -1.2% |
| Mar 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $46.77 | $45.93 | -1.8% | +1.4% | +0.8% | -0.9% | +1.6% | +1.9% |
| Mar 20 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $49.24 | $49.09 | -0.3% | -1.8% | +0.5% | -2.7% | -1.0% | +1.4% |
| Dec 21 | Wells Fargo | Maintains | Market Perform → Market Perform | — | $52.36 | $44.45 | -15.1% | -29.3% | -1.4% | +11.5% | -2.7% | +0.8% |
| Nov 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $65.58 | $65.04 | -0.8% | -0.3% | -3.0% | +0.1% | -0.4% | -0.8% |
| Nov 13 | Berenberg | Downgrade | Buy → Hold | — | $65.58 | $65.04 | -0.8% | -0.3% | -3.0% | +0.1% | -0.4% | -0.8% |
| Aug 21 | Wells Fargo | Maintains | Market Perform → Market Perform | — | $75.49 | $74.42 | -1.4% | -1.9% | +0.5% | -0.6% | +0.5% | +0.5% |
| Aug 10 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $70.03 | $69.01 | -1.5% | -0.2% | -0.4% | -0.3% | -0.0% | +1.4% |
| Aug 10 | JP Morgan | Maintains | Neutral → Neutral | — | $70.03 | $69.01 | -1.5% | -0.2% | -0.4% | -0.3% | -0.0% | +1.4% |
| Aug 10 | Deutsche Bank | Downgrade | Buy → Hold | — | $70.03 | $69.01 | -1.5% | -0.2% | -0.4% | -0.3% | -0.0% | +1.4% |
| Jul 30 | Argus | Downgrade | Buy → Hold | — | $78.49 | $78.38 | -0.1% | +2.1% | +0.5% | -1.5% | -1.3% | +0.6% |
| Jul 12 | Goldman Sachs | Downgrade | Neutral → Sell | — | $77.72 | $75.72 | -2.6% | -2.2% | -0.2% | -1.1% | +4.0% | -2.1% |
No insider trades available.
8-K · 2.02
!! High
Perrigo Company plc -- 8-K 2.02: Earnings Results
Perrigo Company released Q1 2026 earnings results, with detailed financial performance available in the attached press release for investor evaluation.
May 6
8-K · 8.01
!! High
PERRIGO COMPANY PLC -- 8-K 8.01: Material Event / Announcement
Perrigo Company reclassified its Dermacosmetics business from the Skin Care Category to a separate reporting segment, providing investors clearer visibility into this business unit's financial performance and operational metrics.
Apr 22
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Perrigo secured a $200 million financing arrangement, strengthening its liquidity position and reducing near-term refinancing risk, which should stabilize the stock amid any debt maturity concerns.
Mar 23
8-K
PERRIGO COMPANY PLC -- 8-K Filing
Perrigo Company is providing adjusted financial measures to offer investors greater insight into management's operational assessment and planning methodology for evaluating business performance.
Feb 26
Data updated apr 26, 2026 8:38pm
· Source: massive.com